BIT's 2nd Annual World Congress of Biosimilars and Generics
About Conference

WCBG-2018 will host leading scientists from the academia and industry worldwide, to discuss the latest developments in Biosimilars and Generics. 200 participants from 30 countries will gather in beautiful Dalian for the event. 50% of attendees will from the pharmaceutical industry with an additional 50% from academia. With Generics development in Asia growing so rapidly, the WCBG-2018 promises to be one of the most exciting opportunities for those who are seeking to broaden their professional network!

Highlights of the Conference

● Celebrations for 65th Anniversary of the Discovery of DNA Double Helix
● Organizing Great Ceremony with 10,000+ Participants
● Shooting for 1,000 Oral Presentations and Hot Paper Briefing in Whole Spectrum of Bioscience, Biotechnology and Bio-economy
● Gathering 150+ Exhibitors in Cutting-edge Technologies and Bioproducts
● Inviting Worldwide Pharmaceutical expert, Investors, and Decision Makers for the Reunion from 100+ Countries
● 100+ Top Generic Companies Worldwide to Participate
● Project Roadshow and Project Docking Provides Opportunities for Enterprise Networking
● Successful Case Studies for local JVs and M&A
● Business & Career Development, and Talent Search
● Post Tour to Explore the Beauty of Beijing, Dalian, Xi’an

Nobel Laureates-2018
Dr. Edvard Ingjald Moser, 
Professor and Director of the Kavli Institute for Systems Neuroscience at NTNU, Norway Nobel Prize Laureate in Physiology or Medicine, 2014
Dr. Aaron Ciechanover,
Distinguished Research Professor, Technion – Israel Institute of Technology in Haifa, Israel Nobel Prize Laureate in Chemistry, 2004
Inviting&Confirmed Speakers
说明: https://static1.squarespace.com/static/53bafd3ce4b0ae714af7153f/t/53cc7c2de4b0640068f5d9ef/1405910061361/Brian+Harvey+Bio?format=300w Dr. Brian Harvey
Former U.S. FDA Director,
EVP Scientific Regulatory Affairs, Global Liver Institute,
USA
说明: AAEAAQAAAAAAAAjyAAAAJDFmYjJmNjlmLTFhNTMtNDZkYS05NDMwLWQ2NGVjOWEzMTk3Mw.jpg Mr. Salil Kallianpur
Executive Vice President,
GSK,
India
说明: ShinJae-Chang-e1390370510870.jpg Dr. James Cai
Vice President Global Regulatory Affairs, Access & Policy,
Amgen Shanghai, China
说明: http://www.eworld-procurement.com/wp-content/uploads/2014/06/Sammy-Rashed-Beyond-Group.jpg Mr. Sammy Rashed
Global Head,
Novartis Pharma,
Switzerland
说明: AAEAAQAAAAAAAAqPAAAAJGMyZTRjMmQ2LTNhNjktNGQ2Yi05ZGFhLTkwYWZhNWY2MzU4Mw.jpg Dr. Dinesh KHOKAL
Director,
Amgen,
Singapore
说明: 无人图.jpg Dr. Lina Patel
Director, Quality Operations Laboratories,
Merck & Co., Inc.,
USA
说明: C:\Documents and Settings\lihefang\Application Data\Foxmail\FoxTemp6.5(220)\image001(08-31-08-29-04).jpg Dr. Stephan O. Krause
Director of QA Technical Support,
AstraZeneca Biologics, USA
说明: Linglon Zou.jpg Dr. Linglon Zou
Senior Director of Biologics,
Teva Pharmaceuticals,
USA
说明: 14212728_1277608408950153_8270424067945877418_n Dr. Asif Mahmood
Associate Vice President,
Pfizer Inc.,
USA 
说明: Niraj Chhaya.jpg Dr. Niraj Chhaya
Lead Risk Management, Global Pharmacovigilance,
Boehringer Ingelheim Pharma GmbH Co. KG,
Germany
说明: Mostafa.Nakach.jpg Dr. Mostafa.Nakach
Head of Pharmaceutical engineering-Paris,
Sanofi Aventis,
France
说明: 到了富森 Mr. Likun Wang
Director,
Jiangsu Hengrui Medicine Co., Ltd.,
China
说明: Candida Fratazzi.jpg Dr. Candida Fratazzi
President,
BBCR Consulting,
USA
说明: 11874eb.jpg Ms. Divya Chadha Manek
Head of Business Development (Commercial),
NIHR Clinical Research Network,
UK
说明: subir basak.jpg Dr. Subir Basak
CEO,
Celestial Biologicals,
India
说明: Gerry McGettigan.jpg Mr. Gerry McGettigan
CEO & Regultory Expert,
Kinesys Consulting Ltd,
UK
说明: Vivek Mittal.jpg Dr. Vivek Mittal
Vice President,
Health Advances, LLC,
USA
说明: Dinesh Dua.jpg Dr. Dinesh Dua
Vice Chairman,
Pharmexcil,
India
说明: Dieter Tzschoppe.jpg Dr. Dieter Tzschoppe
Director Operations Biotechnology / Pure and Applied organic Chemistry,
European Patent Office,
Germany
说明: Dinah Duarte.jpg Dr. Dinah Duarte
Head of Scientific Evaluation Unit,
National Authority of Medicines and Health Products,I.P,
Portugal
说明: Jianguo Yang.png Dr. Karen Wen
President,,
Mycenax Biotech Inc.,
Taiwan
说明: Bracha Timan.jpg Dr. Bracha Timan
Director Head of Bioassays & Technology,
Teva Pharmaceuticals Ltd.,
Israel
说明: Jacob Glanville.jpg Dr. Jacob Glanville
Director,
Distributed Bio, Inc.,
USA
说明: JuHong Liu.jpg Dr. JuHong Liu
FDA,
USA
说明: Mick Foy.jpg Mr. Mick Foy
Group Manager,
Medicines and Healthcare Products Regulatory Agency,
UK
说明: Raphael Nudelman.jpg Dr. Raphael Nudelman
Associate Director, Head of Chemical & Computational Toxicology, Teva Pharmaceutical Industries Ltd, 
Israel
说明: Shubhadeep Sinha.jpg Dr. Shubhadeep Sinha
Vice President, Head Global Operations,
Hetero Drugs Ltd,
India
说明: Leandro Mieravilla.jpg Mr. Leandro Mieravilla
Global Market Manager,
Cassara Biotech Canada,
Canada
说明: Roberto Frontini.jpeg Dr. Roberto Frontini
Director,
EAHP,
Germany
说明: Thomas Schulze.jpg Dr. Thomas Schulze
Vice President,
EirGenix Inc.,
Taiwan
说明: Sunny Wang.jpg Ms. Sunny Wang
Global Head, Patent Operations,
Sanofi-Aventis,
France
说明: https://static1.squarespace.com/static/57f76ff1f7e0ab123767ec88/t/582e2719d1758e98bd8c71d9/1479420053138/Ruud+Brands?format=300w Mr. Ruud Brands
President,
Alloksys Life Sciences BV,
The Netherlands
说明: https://media.licdn.com/mpr/mpr/shrinknp_400_400/p/1/000/067/2b9/151a6b8.jpg Dr. Fernando Salles
Vice President, Global Business Development,
Teva Pharmaceuticals,
USA
Dr. Hong Chen
Vice President, YILING
PHARMACEUTICAL, China
Dr. Chih-Jung Chang
Vice President, EirGenix, Inc. Taiwan
Mr. Yi Huang
Sr. Manager of SCD,
Biologics. USP-China, China
Previous Event
Previous Participants
Exhibition and Sponsorship

WCBG-2018 provides an ideal platform to showcase your new technologies and products in Dalian. And it is developed to maximize your exposure, generate new leads, build brand awareness, and solidify business relations. WCBG-2018 is one of the most effective international marketing platforms in the field of generics, which offers a wide range of sponsoring categories for branding and highlighting your company in order to achieve the best publicity.

    
Scenery of Dalian

Dalian — the "Northern Pearl" and summer resort of China, compared to ancient capital cities such as Beijing, Xian, Nanjing or Luoyang, is a young city with only a 100-year history. Situated at the tip of China's Liaodong Peninsular, it is a trading and financial center in northeastern Asia and has gained the name the 'Hong Kong of Northern China'. It is one of the most popular tourist spots in China, offering an intriguing blend of modern and traditional Chinese culture.

        
News update

Program released already!
● Call for Session Chairs and Speakers
● Call for Exhibitors and Sponsors
● Call for Media Partners and Advertisers

Abstract Format Download
Hosting Organizations
whtslogo.JPG

World High Technology Society (WHTS)

Operating Organizations



Zhen-Ao Group Co., Ltd.


SHUANGDI, INC.

BIT Group Global Ltd.

Official Travel Agency
International Chairman


Dr. Stephan O. Krause
Director of QA Technical Support,
AstraZeneca Biologics,
USA

Sponsors

Media Partners

BIT’s Upcoming Events
Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China]
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2016-2017 BIT Congress Inc.